CorMedix (CRMD) EBITDA Margin Growth (1y) (2014 - 2025)
CorMedix (CRMD) EBITDA Margin Growth (1y) (2014 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1,552.00 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1,536.00 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -170.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1,049.00 |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | CorMedix | 546.82 Mn | 391.62 Mn | 107.31 Mn | 452.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 452.00 |
| Sep 30, 2025 | 7,794.00 |
| Jun 30, 2025 | 194,727.00 |
| Dec 31, 2022 | -1.44 Mn |
| Sep 30, 2022 | -7.96 Mn |
| Jun 30, 2022 | 3.30 Mn |
| Mar 31, 2022 | -8.39 Mn |
| Dec 31, 2021 | -287,372.00 |
| Sep 30, 2021 | -1.54 Mn |
| Jun 30, 2021 | -1.76 Mn |
| Mar 31, 2021 | -59,163.00 |
| Dec 31, 2020 | 1.08 Mn |
| Sep 30, 2020 | 158,796.00 |
| Jun 30, 2020 | -3.86 Mn |
| Mar 31, 2020 | -457,033.00 |
| Dec 31, 2019 | -2.98 Mn |
| Sep 30, 2019 | -593,796.00 |
| Jun 30, 2019 | 9.78 Mn |
| Mar 31, 2019 | 4.09 Mn |
| Dec 31, 2018 | 1.92 Mn |